Status:
RECRUITING
Preemptive Oral Lactium to Prevent Emergence Agitation
Lead Sponsor:
Tanta University
Conditions:
Lactium
Emergence Agitation
Eligibility:
All Genders
3-7 years
Phase:
NA
Brief Summary
This prospective randomized controlled study will be conducted to evaluate the effects of preoperative lactium on the incidence and severity of emergence agitation in children undergoing adenotonsille...
Detailed Description
Emergence agitation is a frequent postoperative complication in pediatric patients receiving inhalational anesthetics with a rapid recovery profile, e.g. sevoflurane. There is a wide variation in the ...
Eligibility Criteria
Inclusion
- Both gender
- 4 to 7 years age
- American Society of Anesthesiologists (ASA) Physical Status I or II
- Scheduled for adenotonsillectomy surgery under sevoflurane anesthesia
Exclusion
- Parents declined to participate in the trial
- Children with behavioral changes; neurological or psychiatric diseases
- Physical or developmental delay
- Sedative or anticonvulsant medication
- Pre-existing renal or cardiovascular disease, bone disease, or gastrointestinal disorders
- • History of lactose intolerance
Key Trial Info
Start Date :
September 22 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 25 2026
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT07172594
Start Date
September 22 2025
End Date
February 25 2026
Last Update
September 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University
Tanta, Gharbia Governorate, Egypt, 31527